50 microgram matrix m adjuvant
chief executive officer novavax
chief executive officer sk bioscience
coronavirus spike s protein
country: unknown
novavax' recombinant nanoparticle technology
proteinbasedvaccinecandidate
saponin based matrix m adjuvant
stanley c erck president
two pivotal phase 3 trials